Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Initial Treatment for COPD/Asthma Exacerbation with Bronchitis

Bronchodilator Therapy

  • The American College of Chest Physicians recommends short-acting beta-agonists to control bronchospasm and relieve dyspnea in patients with stable COPD/asthma with bronchitis 3
  • The initial treatment for a COPD/asthma exacerbation with bronchitis should include short-acting inhaled beta2-agonists with or without short-acting anticholinergics 1
  • For moderate exacerbations, either a short-acting beta2-agonist or a short-acting muscarinic antagonist like ipratropium can be given via nebulizer 1
  • Nebulized bronchodilators should be given upon arrival and at 4-6 hourly intervals thereafter, but may be used more frequently if required 1

Systemic Corticosteroids

  • Systemic glucocorticoids should be administered promptly as they improve lung function, oxygenation, and shorten recovery time and hospitalization duration 1
  • A dose of 40 mg prednisone per day for 5 days is recommended 1
  • Duration of therapy should not exceed 5-7 days to minimize side effects 1
  • Long-term therapy with oral corticosteroids is not recommended due to adverse effects 2

Antibiotic Therapy

  • Antibiotics should be given to patients with acute exacerbations who have three cardinal symptoms: increased dyspnea, increased sputum volume, and increased sputum purulence 1
  • The recommended duration of antibiotic therapy is 5-7 days 1
  • First-line antibiotics include amoxicillin or tetracycline unless previously used with poor response 1

Oxygen Therapy

  • Supplemental oxygen should be administered to maintain SpO2 ≥90% without causing respiratory acidosis 1
  • In patients with known COPD aged 50 years or older, initial FiO2 should not exceed 28% via Venturi mask or 2 L/min via nasal cannulae until arterial blood gases are known 1

Treatment Considerations Based on Disease Severity

  • Noninvasive ventilation (NIV) should be considered for patients with acute respiratory failure, as it improves gas exchange, reduces work of breathing, decreases hospitalization duration, and improves survival 1
  • While long-acting bronchodilators (LABAs, LAMAs) are effective for maintenance therapy in stable COPD, they are not the first choice for acute exacerbations due to their slower onset of action 2, 4

Treatment Algorithm

  • The treatment algorithm for COPD/asthma exacerbation with bronchitis includes administering short-acting bronchodilators, starting systemic corticosteroids, adding appropriate antibiotics if necessary, providing controlled oxygen therapy, and considering NIV for patients with respiratory failure 1, 2, 4